For more predictive and biologically relevant results in preclinical testing
Early compound de-risking decisions require in vitro data with highest possible biological relevance. Now you can bring far greater assurance to such decisions with InSphero 3D InSight™ organotypic microtissue models and services.
- Morphologically and functionally superior 3D model with long lifetime
- Supplied ready-to-use with validated 3D assay protocols
- No risk of assay artefacts due to artificial scaffold materials
To learn more about InSphero microtissues, services and kits please contact us.